Economic Burden of Eosinophilic Esophagitis: A Nationwide Cost-of-Illness Study.

Autor:	Bozorg SR; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Division of Gastroenterology, Karolinska University Hospital, Stockholm, Sweden.; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Söderling J; Clinical Epidemiology Division, Department of Medicine, Karolinska Institutet, Gothenburg, Sweden., Mårild K; Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden.; Department of Pediatric Gastroenterology, Queen Silvia Children's Hospital, Gothenburg, Sweden., Garber JJ; Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Uchida A; Division of Gastroenterology, Hepatology and Nutrition, University of Utah School of Medicine, Salt Lake City, Utah, USA., Neovius M; Clinical Epidemiology Division, Department of Medicine, Karolinska Institutet, Gothenburg, Sweden., Ludvigsson JF; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Department of Pediatrics, Örebro University Hospital, Örebro, Sweden.; Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA., Everhov ÅH; Clinical Epidemiology Division, Department of Medicine, Karolinska Institutet, Gothenburg, Sweden.; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden .
Jazyk:	angličtina
Zdroj:	The American journal of gastroenterology [Am J Gastroenterol] 2024 Oct 01; Vol. 119 (10), pp. 2122-2125. Date of Electronic Publication: 2024 Mar 25.
DOI:	10.14309/ajg.0000000000002868
Abstrakt:	Introduction: Despite its increasing prevalence, the economic impact of eosinophilic esophagitis (EoE) is understudied. Methods: We estimated the societal economic burden of EoE by using real-world data from Swedish health registers. Results: Patients with EoE had 45% higher societal cost ($6,290 vs $4,349) compared with the general population, primarily driven by increased healthcare costs ($2,414 vs $1,022), which accounted for 72% of the excess societal cost in EoE. Discussion: EoE is associated with a considerable economic burden to society. With the prevalence of EoE still rising, the economic burden of EoE is expected to continue to grow. (Copyright © 2024 by The American College of Gastroenterology.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu